A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the safety, tolerability, and preliminaryefficacy of SFL‐0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
Epistemonikos ID: 099af275178d407c30f625ac200c8aa0ff368df6
First added on: Sep 01, 2026